Shilpa Biologicals CEO Dr Sridevi Khambhampaty Resigns
Hyderabad: Shilpa Medicare Limited has informed the stock exchanges that Dr Sridevi Khambhampaty has resigned as Chief Executive Officer (CEO) of its material subsidiary, Shilpa Biologicals Private Limited, due to personal commitments.
The company disclosed the development under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, stating that Dr Khambhampaty tendered her resignation through a letter dated April 15, 2026. She will cease to hold the position with effect from the close of business hours on July 15, 2026.
According to the regulatory filing, Dr. Khambhampaty cited personal commitments as the reason for stepping down from the role after serving the required notice period.
Also Read: Shilpa Medicare Unit Invests Euro 7 Million in Brain Cancer Drug Developer Gate2Brain
In her resignation letter addressed to the Board of Shilpa Biologicals, she thanked the company for the opportunity to lead the biologics business and expressed confidence in the future growth of the company. She also conveyed her best wishes to the organisation.
Shilpa Biologicals Private Limited is the biotechnology arm of Shilpa Medicare and is engaged in the research, development and manufacturing of biologics and biopharmaceutical products.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.